{"disease":{"id":"rapidly-progressive-interstitial-lung-disease","name":"rapidly progressive interstitial lung disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06919380","title":"Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Li Shiyue","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}